Literature DB >> 33664781

Suppressing evolution in genetically engineered systems through repeated supplementation.

Nathan C Layman1, Beth M Tuschhoff2, Andrew J Basinski2, Christopher H Remien2, James J Bull1, Scott L Nuismer1.   

Abstract

Genetically engineered organisms are prone to evolve in response to the engineering. This evolution is often undesirable and can negatively affect the purpose of the engineering. Methods that maintain the stability of engineered genomes are therefore critical to the successful design and use of genetically engineered organisms. One potential method to limit unwanted evolution is by taking advantage of the ability of gene flow to counter local adaption, a process of supplementation. Here, we investigate the feasibility of supplementation as a mechanism to offset the evolutionary degradation of a transgene in three model systems: a bioreactor, a gene drive, and a transmissible vaccine. In each model, continual introduction from a stock is used to balance mutation and selection against the transgene. Each system has its unique features. The bioreactor system is especially tractable and has a simple answer: The level of supplementation required to maintain the transgene at a frequency p ^ is approximately p ^ s , where s is the selective disadvantage of the transgene. Supplementation is also feasible in the transmissible vaccine case but is probably not practical to prevent the evolution of resistance against a gene drive. We note, however, that the continual replacement of even a small fraction of a large population can be challenging, limiting the usefulness of supplementation as a means of controlling unwanted evolution.
© 2020 The Authors. Evolutionary Applications published by John Wiley & Sons Ltd.

Entities:  

Keywords:  bioreactor; gene drive; gene flow; genetic engineering; swamping; transmissible vaccine

Year:  2020        PMID: 33664781      PMCID: PMC7896713          DOI: 10.1111/eva.13119

Source DB:  PubMed          Journal:  Evol Appl        ISSN: 1752-4571            Impact factor:   5.183


  44 in total

1.  Natural selection in populations subject to a migration load.

Authors:  Daniel I Bolnick; Patrik Nosil
Journal:  Evolution       Date:  2007-09       Impact factor: 3.694

2.  Gene flow and selection in a cline.

Authors:  M Slatkin
Journal:  Genetics       Date:  1973-12       Impact factor: 4.562

3.  Can transgenic mosquitoes afford the fitness cost?

Authors:  Louis Lambrechts; Jacob C Koella; Christophe Boëte
Journal:  Trends Parasitol       Date:  2007-12-27

4.  Expression in Escherichia coli of a chemically synthesized gene for the hormone somatostatin.

Authors:  K Itakura; T Hirose; R Crea; A D Riggs; H L Heyneker; F Bolivar; H W Boyer
Journal:  Science       Date:  1977-12-09       Impact factor: 47.728

Review 5.  Spontaneous mutation rates come into focus in Escherichia coli.

Authors:  Ashley B Williams
Journal:  DNA Repair (Amst)       Date:  2014-10-11

6.  Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose.

Authors:  Jasdave S Chahal; Omar F Khan; Christopher L Cooper; Justine S McPartlan; Jonathan K Tsosie; Lucas D Tilley; Saima M Sidik; Sebastian Lourido; Robert Langer; Sina Bavari; Hidde L Ploegh; Daniel G Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-05       Impact factor: 11.205

7.  Spectra of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice.

Authors:  S W Kohler; G S Provost; A Fieck; P L Kretz; W O Bullock; J A Sorge; D L Putman; J M Short
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

Review 8.  Transmissible Viral Vaccines.

Authors:  James J Bull; Mark W Smithson; Scott L Nuismer
Journal:  Trends Microbiol       Date:  2017-10-13       Impact factor: 17.079

9.  Evaluating the promise of recombinant transmissible vaccines.

Authors:  Andrew J Basinski; Tanner J Varrelman; Mark W Smithson; Ryan H May; Christopher H Remien; Scott L Nuismer
Journal:  Vaccine       Date:  2017-12-24       Impact factor: 3.641

10.  A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae.

Authors:  Andrew Hammond; Roberto Galizi; Kyros Kyrou; Alekos Simoni; Carla Siniscalchi; Dimitris Katsanos; Matthew Gribble; Dean Baker; Eric Marois; Steven Russell; Austin Burt; Nikolai Windbichler; Andrea Crisanti; Tony Nolan
Journal:  Nat Biotechnol       Date:  2015-12-07       Impact factor: 54.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.